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Cellular/Molecular
Drp2 and Periaxin Form Cajal Bands with Dystroglycan But
Have Distinct Roles in Schwann Cell Growth
Diane L. Sherman, Lai Man N. Wu, Matthew Grove, C. Stewart Gillespie, and Peter J. Brophy
Centre for Neuroregeneration, University of Edinburgh, Edinburgh EH16 4SB, United Kingdom
Cajal bands are cytoplasmic channels flanked by appositions where the abaxonal surface of Schwann cell myelin apposes and adheres to
the overlying plasma membrane. These appositions contain a dystroglycan complex that includes periaxin and dystrophin-related
protein 2 (Drp2). Loss of periaxin disrupts appositions and Cajal bands in Schwann cells and causes a severe demyelinating neuropathy
inmouse andhuman.Here, we investigated the role ofmouseDrp2 in apposition assembly andCajal band function and compared it with
periaxin. We show that periaxin and Drp2 are not only both required to form appositions, but they must also interact. Periaxin–Drp2
interaction is also required for Drp2 phosphorylation, but phosphorylation is not required for the assembly of appositions. Drp2 loss
causes corresponding increases in Dystrophin family members, utrophin and dystrophin Dp116, although dystroglycan remains un-
changed. We also show that all dystroglycan complexes in Schwann cells use the uncleaved form of-dystroglycan. Drp2-null Schwann
cells have disrupted appositions and Cajal bands, and they undergo focal hypermyelination and concomitant demyelination. Neverthe-
less, they do not have the short internodal lengths and associated reduced nerve conduction velocity seen in the absence of periaxin,
showing that periaxin regulates Schwann cell elongation independent of its role in the dystroglycan complex. We conclude that the
primary role of the dystroglycan complex in appositions is to stabilize and limit the radial growth of myelin.
Introduction
Dystroglycan complexes link extracellularmatrix proteins suchas
laminin with the actin cytoskeleton by means of the extracellular
-subunit and the transmembrane -subunit of dystroglycan
(Ervasti and Campbell, 1993). In skeletal muscle, dystroglycan
complexes involving dystrophin family members dystrophin and
utrophin (dystrophin-related protein 1) regulate the segregation
of the plasma membrane into distinct domains (Ibraghimov-
Beskrovnaya et al., 1992; Tinsley et al., 1993; Colognato et al., 1999;
CohnandCampbell, 2000).Dystroglycan complexes are also critical
for the establishment of basal membrane polarity in epithelial cells
(Durbeej et al., 1995; Li et al., 2003).
Dystroglycan complexes in myelinating Schwann cells of
the vertebrate peripheral nervous system (PNS) use dystrophin
(Dp116), utrophin, or dystrophin-related protein 2 (Drp2)
(Matsumura et al., 1993; Yamada et al., 1994; Saito et al., 1999;
Imamura et al., 2000; Sherman et al., 2001; Albrecht et al., 2008;
Masaki and Matsumura, 2010). Drp2 interacts with periaxin to
form the periaxin–Drp2–dystroglycan (PDG) complex, which is
concentrated at zones of adhesion between the abaxonal surface
of compact peripheralmyelin and the Schwann cell plasmamem-
brane (Gillespie et al., 1994, 2000; Sherman et al., 2001; Court et
al., 2004) (see Fig. 1A). These appositions define the boundaries
of cytoplasm-filled channels that were first described histologi-
cally at the beginningof the 20th century (Nageotte, 1910;Nemiloff,
1910; Ramo´n y Cajal, 1912), and more recently by scanning EM
(Ushiki and Ide, 1987). These channels have been named Cajal
bands andmay have a biosynthetic role inmyelin assembly (Ramo´n
y Cajal, 1933; Ushiki and Ide, 1987; Court et al., 2004). Correlation
between their integrity and the longitudinal growthof Schwanncells
has implicated Cajal bands in defining internodal length (Court et
al., 2004, 2009). Recently, a model has been proposed whereby reg-
ulatedcleavageof-dystroglycan toa31kDa formmight control the
relative sizes of appositions and Cajal bands thereby influencing in-
ternodal length (Court et al., 2011).
Loss of periaxin causes demyelination in mice and a recessive
form of a severe demyelinating neuropathy in humans, CMT4F
(Charcot–Marie–Tooth 4F) (Gillespie et al., 2000; Boerkoel et al.,
2001; Guilbot et al., 2001). However, it is not clear whether this
disease is primarily the result of the disruption of appositions,
and therefore Cajal bands; it is also not certain whether the re-
duced internodal lengths observed in periaxin-null Schwann cells
are an additional consequence of the disruption of Cajal bands.
To shed further light on the mechanisms of assembly and the
function of Cajal bands, we sought to disrupt the PDG complex
by an alternative approach, namely by eliminating Drp2. Here,
we show that, although periaxin and Drp2 cooperate to form
appositions and Cajal bands, they have distinct functions in my-
elinating Schwann cells. Importantly, we show that the primary
role of appositions and Cajal bands is to limit radial myelin
growth rather than regulate Schwann cell elongation.
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Materials andMethods
Mice.All animal work conformed to United Kingdom legislation (Scien-
tific Procedures) Act 1986, and to the University of Edinburgh Ethical
Review Committee policy. Cnp1-Cre mice have been described and
shown to be effective in promoting Cre-mediated recombination in
mouse embryonic peripheral nerves (Lappe-Siefke et al., 2003; Grove et
al., 2007; Sherman et al., 2012). Hprt-Cre mice (Su et al., 2002) (from
John Mason, University of Edinburgh, Edinburgh, UK) were used to
drive germ line recombination and inactivation of the Drp2 gene and
FLPe mice (Wallace et al., 2007) (from Andrew Smith, University of
Edinburgh, Edinburgh, UK) were used to drive recombination and exci-
sion between Frt sites. Mice carrying a Drp2 floxed allele were generated
by homologous recombination in E14-TG2a.IV (129/Ola strain) ES cells
by methods described previously (Sherman et al., 2005). The strategy
used for gene targeting is summarized in Figure 1B. The replacement
targeting vector contained two loxP sequences in the same orientation.
The first loxP sequence was inserted at a SmaI site in intron 3, 1990 bp
upstream of exon 4, and the other loxP sequence was at the 3 of a
frt/PGKpA/neo/EM7/PGK/frt/loxP cassette (gift fromDr. Andrew Smith,
University of Edinburgh, Edinburgh, UK), which was introduced at an
NsiI site in intron 4 located 520 bp downstream of the end of exon 4. A
HindIII–XhoIfragmentcontainingMC1-DTA-PGKpAfrompMC1DTApA(a
gift from Dr. Takeshi Yagi, Osaka University, Osaka, Japan) was ligated
to the 3 end of the targeting clone. For the initial targeting, ES cells were
selected in G418 only and resistant clones screened by correct targeting
was confirmed by Southern blot analysis of AvrII-digested genomicDNA
by hybridization with a 3 probe external to the homology region and
using a probe 5 to exon 4 to show the presence of the LoxP site with
HindIII-digested DNA. The 5 probe detected a 7.8 kb fragment corre-
sponding to the wild-type (WT) allele and a 1.3 kb fragment correspond-
ing to the targeted allele and the 3 probe detected a 9.6 kb fragment
corresponding to the wild-type allele, and an 11.4 kb fragment corre-
sponding to the targeted allele. Two correctly targeted clones were in-
jected into blastocysts. Both clones gave good germ line transmitting
chimeras in test crosses with the C57BL/6 strain, and offspring heterozy-
gous for the correctly targeted allele were subsequently identified by ear
biopsy and PCR analysis. One of these lines was crossed with the FLPeR
deleter mouse to remove the neo cassette. Heterozygotes were then back-
crossed onto the C57BL/6 background for at least 10 generations before
experimental analysis. Genotyping of Drp2fl/Y/Cnp1-Cre/ mice by
successive PCRs of genomic DNA extracted from ear biopsies was using
the following primers, first 5-GCTATTCTTGTAGGCGGACCT-3 and
5-GGGTCACTGGAGGTCACTGT-3, yielding a 471 bp product,
which after HindIII digestion yielded a 309 and a 162 bp fragment for the
floxed allele but remained undigested for thewild-type allele. Second, the
presence ofCrewas detected as described previously (Lappe-Siefke et al.,
2003). Detection of the recombined allele in Drp2/y or Drp2/mice
was by PCR using 5-TCCTAACACAAGTGATGCCTGTAGC-3 and
5-TTCAGCAAGGGGATGAGAGTCC-3 and yielded a 529 bp product.
Mice lacking Drp2 in Schwann cells were generated by crossing male
mice carrying a floxed allele ofDrp2 (Drp2 is on theX chromosome)with
Cnp1-Cremice. We have shown previously that the Cnp1-Cre driver line
is effective in Schwann cells during embryonic development before the
radial sorting of axons (Grove et al., 2007; Sherman et al., 2012).
Transgenic mice were generated by pronuclear injection using meth-
ods previously described (Sherman and Brophy, 2000). We used a well
characterized promoter generously provided by John Bermingham
(McLaughlin Research Institute, Great Falls, MT) and Steven Scherer
(University of Pennsylvania School of Medicine, Philadelphia, PA) com-
prising a 1.1 kb fragment containing the rat Mpz promoter fused to the
human GJB1 gene, which is known to drive expression specifically in
Schwann cells (Abel et al., 1999; Scherer et al., 2005; Jeng et al., 2006).
Transgenicmice expressed a cDNAencodingmouseDrp2 obtained from
the IMAGE consortium with a FLAG tag sequence fused at its 3 end
(Drp2Tg). The codons encoding S748 and T910 were mutated to alanine
codons in the Drp2 cDNA by site-directed mutagenesis using
QuikChange (Stratagene) to generate mice expressing nonphosphory-
lated Drp2 (Drp2Tg). This transgenic protein also had a C-terminal
FLAG tag. A transgenic mouse expressing the cDNA encoding mouse
periaxin (PrxTg) was generated by RT-PCR and a FLAG tag fused at its 5
end. A transgenic that expressed periaxin lacking the Drp2 binding site
(PrxTg) was generated after deleting the sequence encoding amino ac-
ids 130–199 by a PCR-ligation technique as described previously (Sher-
man and Brophy, 2000). This also had an N-terminal FLAG tag. After
backcrossing to C57BL/6 for at least six generations, these mice were
interbredwith eitherDrp2/yorPrx/mice so that the transgeneswere
expressed on eitherDrp2- or periaxin-null backgrounds, respectively. To
facilitate breeding for the transgenic studies, instead of using mice in
which Drp2 was inactivated conditionally in Schwann cells, Drp2/y
mice were derived using the Hprt-Cre deleter mouse, since we had pre-
viously shown that Drp2 is predominantly if not exclusively expressed in
myelinating Schwann cells in themurine nervous system (Sherman et al.,
2001). Utr/ mice were on a DBA/C57BL/6 background and were a
generous gift fromKayDavies (OxfordUniversity, Oxford, UK) (Decon-
inck et al., 1997).
Immunostaining, Western blotting, histology, and in situ hybridization.
All histology and immunofluorescence analyses were performed on
quadriceps nerves unless specified otherwise. The perineurium was re-
moved before immunostaining of teased fibers. Further preparation and
the method for immunostaining of cryosections or teased fiber prepara-
tions were as described previously (Sherman et al., 2005, 2012; Grove et
al., 2007). Primary antibodies were used at the following dilutions for
immunostaining or Western blotting as indicated. Chicken anti-Po
(Aves Labs; 1:200 for immunostaining), mouse anti--dystroglycan
(Novocastra; 43DAG1/8D5; 1:50 for Western blotting), rabbit anti-
Drp2.2222 (anti-CWNEIKKKSHNLRARLEA in exon 4; 1:200 for im-
munostaining), rat anti-E-cadherin (Zymed; for immunostaining;
1:1000). All other primary and secondary antibodies and nuclear stains
have been described previously (Tait et al., 2000; Sherman et al., 2001,
2012). Conventional fluorescence microscopy was performed using an
Olympus BX60 microscope, and images were captured using a
Hamamatsu Orca-ER camera and Improvision Openlab software. For
confocal microscopy, we used a Leica TCL-SL confocal microscope with
either a 40 or a 63 objective, 1.4 NA, and Leica proprietary software.
The acquired stacks were assembled using themaximumprojection tool,
and all figures were prepared using Adobe Photoshop CS4 extended,
version 11, and were not subjected to any subsequent image processing.
Western blotting was performed as described previously (Sherman et al.,
2005) on sciatic nerve lysates prepared in 1% NP-40, 0.5% sodium de-
oxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1 mM sodium orthovanadate, 2 mM sodium pyrophosphate,
10 mM NaF with proteinase inhibitors, 1 mM benzamidine, 0.5 mM
7-amino-1-chloro-3-tosylamido-2-heptanone (TLCK), 1 mM PMSF,
and leupeptin and antipain, both 10 mg/ml. For electron microscopy,
mice were perfused intravascularly with 2.5% glutaraldehyde and 4%
paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. Nerves
were removed, fixed for 2 h at room temperature, then 18 h at 4°C in the
same fixative, postfixed in OsO4, and embedded in Araldite. Ultrathin
sections were stained with uranyl acetate and lead citrate and examined
on a Phillips BioTwin CM120 electron microscope equipped with a Ga-
tan Orius camera. Light micrographs were of toluidine blue-stained
transverse sections of quadriceps nerve. In situ hybridization for my-
elin basic protein (MBP) mRNA was performed as described previ-
ously (Court et al., 2004), and surface intensities were plotted using
NIH ImageJ.
Phosphopeptide mapping, GST pull downs, kinase and phosphatase
assays. The rabbit anti-Drp2.2222 antibody was used to immunopre-
cipitate Drp2 from mouse peripheral nerve lysates. The immunopre-
cipitate was resolved by SDS-PAGE and the Drp2 band was identified
using SimplyBlue (Invitrogen). The band was cut out, washed with
acetonitrile, and frozen. Following in-gel digestion by trypsin, chy-
motrypsin, and endoproteinase AspN, sequence analysis of proteo-
lytic fragments was performed by microcapillary reverse-phase HPLC
nano-electrospray tandem mass spectrometry (ALC/MS/MS) on a
Finnigan LCQDECA XP Plus quadrupole ion trap mass spectrometer
at the Microchemistry and Proteomics Analysis Facility (Harvard
University, Cambridge, MA).
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GST-fusion proteins were expressed and purified as described previ-
ously (Sherman et al., 2001). The GST sequence was ligated with a cDNA
encoding amino acids 723–957 in the C terminus ofDrp2 and the codons
encoding S748 and T910 were mutated to alanine codons in the Drp2
cDNA by site-directedmutagenesis usingQuikChange (Stratagene). The
purified proteins (30 g) were incubated while attached to glutathione-
Sepharose beads (GE Healthcare) with 250 l of peripheral nerve lysate
and incubated for 3 h at 4°C. The beads were then washed three times
with lysis buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 1mMEDTA, phosphatase inhibitors, 1mM sodiumorthovanadate,
2 mM sodium pyrophosphate, 10 mM NaF) with proteinase inhibitors (1
mM benzamidine, 0.5 mM TLCK, 1 mM PMSF, and leupeptin and anti-
pain, both 10g/ml). The beadswerewashed twicewith kinase buffer, 20
mM HEPES, pH 7.5, 20 mM MgCl2, phosphatase inhibitors, 2 mM DTT,
and then resuspended in 30l of the same buf-
ferwith 33MATPand 5Ci of [- 32P]ATP at
30°C for 20 min. Reactions were stopped by
SDS-PAGE sample buffer, and proteins were
resolved by SDS-PAGE. Phosphorylation was
visualized by autoradiography.
For dephosphorylation of Drp2, sciatic
nerve extracts were extracted in 1% Triton
X-100, 100 mM NaCl, 10 mM MgCl2, 50 mM
Tris-HCl, pH 8.0, with proteinase inhibitors
and incubatedwith 20Uof calf intestinal phos-
phatase (New England Biolabs) in the presence
or absence of phosphatase inhibitors at 37°C in
a total volume of 25 l.
Crush injury, electrophysiology, and Rotarod.
Crush injury of sciatic nerves was performed
similar to as described previously (Williams
and Brophy, 2002). Two-month-oldmice were
anesthetized, and the right sciatic nerve was ex-
posed under anesthesia and crushed distal to
the sciatic notch. Crush was performed for 3 s
three times with a number 5 fine forceps.
Acutely prepared quadriceps nerves, taken
from 3-month- and 6-month-old control and
mutantmice, were placed in oxygenatedmam-
malian HEPES physiological solution (137 mM
NaCl, 5 mMKCl, 2mMCaCl2, 1 mMMgCl2, 5.5
mM D-glucose, and 5 mM HEPES, pH 7.2–7.4)
and nerve conduction velocities measured as
described previously (Court et al., 2004). Ac-
celerating Rotarod analysis of mice at 3 and 6
months (minimum of 13 per group) was per-
formed as described previously (Zonta et al.,
2011).
Morphometry. The diameters of axons and
axons plus myelin were measured in electron
micrographs by first measuring the circumfer-
ence of each by hand-tracing using ImageJ
(NIH), and then by calculating areas from
which diameters were derived. Their g ratios
were calculated from these diameters. A mini-
mumof 100 axons was counted per animal and
aminimum of three animals was used per con-
dition. Internodal lengths were measured as de-
scribed usingOpenlab (PerkinElmer) (Court et al.,
2004; Sherman et al., 2012). Aminimumof 100 fi-
bers was counted per mouse for each condition to
quantitate appositions from electron micrographs.
Numbers of Schmidt-Lanterman incisures were
similarly measured after staining teased fibers with
antibodies against Neurofascin (green) and
E-cadherin (red).Aminimumof50measurements
wasmade per animal.
Statistical analysis. Statistical analysis was by
unpaired Student’s t tests with GraphPad
Prism 5.0c software.
Results
Loss of Drp2 disrupts appositions and Cajal bands
WegeneratedmicewithoutDrp2 in Schwann cells as described in
Materials and Methods, and we refer to mice with the genotype
Drp2fl/Y/Cnp1-Cre/ as mutants. The DNA fragment generated
by PCR of peripheral nerve genomic DNA after Cre-mediated
recombination showed effective inactivation of the Drp2 gene
(Fig. 1C). Loss of Drp2 expression in myelinating Schwann cells
was highly efficient, as shown byWestern blot and immunofluo-
rescence microscopy (Fig. 1D,E). Levels of Drp2 in WT and
Drp2fl/Ymice were identical, butDrp2fl/Ymice were considered to
Figure 1. Disruption of the Drp2 gene causes loss of Drp2 andmislocalization of Periaxin. A, Diagram showing the relationship
between the periaxin (Prx)–Drp2–dystroglycan (DG andDG) complex, appositions and Cajal bands in amyelinated peripheral
nerve. MT, Microtubules. B, Gene targeting strategy to generate a floxed Drp2 allele. Exons are numbered and the position of
probes for Southern blotting are shown in gray. DTA, Diphtheria toxin A chain; Neo, neomycin selection cassette; forward arrow-
heads are LoxP sites, and reverse arrowheads are Frt sites. A, AvrII; H, HindIII. The arrows show the position of primers used for
routine genotyping. C, Genomic PCR used to detect recombination in sciatic nerves of Drp2fl/Y/Cnp1-Cre/ (mutant) and
Drp2/ymice.D,Western blot analysis of nerve lysates fromWT,Drp2fl/Y, andDrp2fl/Y/Cnp1-Cre/ (mutant)mice, respectively.
Actinwas the loading control. E, Immunofluorescence analysis of transverse sections of nerve showingDrp2 (red) is not detectable
in themutant. Myelin is labeled with P0 antibody (green) and axons with Neurofilament protein, NF-H antibody (blue). Scale bar,
10m. F, Immunofluorescence staining shows that loss of Drp2 causes mislocalization of periaxin. Scale bar, 10m.
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be the more appropriate control not only genotypically but also
because they were littermates of mutants (Fig. 1D). Drp2 is mis-
localized in the absence of periaxin (Sherman et al., 2001), and
similarly, periaxin inDrp2-null Schwann cells was no longer con-
centrated in patches known to colocalize with appositions (Fig.
1F). Hence, loss of Drp2 disrupted both the PDG complex and
appositions (Fig. 2A–C). Since it was no longer compartmental-
ized, cytoplasm now formed an annulus under the plasma mem-
brane of the Schwann cell (Fig. 2B). Derangement of Cajal bands
affected the accumulation of MBP mRNA at distal paranodal
extremities (Fig. 2D), suggesting that microtubule-based transport
was affected, as has been proposed for periaxin-null Schwann cells
(Court et al., 2004).
In contrast to periaxin-null Schwann cells, and despite their
disrupted Cajal bands, Drp2 mutants had normal internodal
lengths, conduction velocities, and motor behavior (Fig. 3A–C).
Nevertheless, abnormal profiles in themutant increasedwith age,
and at 6months they comprised 6.3 0.6% (mean value SEM)
of mutant nerve fibers (Fig. 4D). These profiles comprised my-
elin outfoldings, focal hypermyelination, and onion bulbs with
thin myelin and supernumerary Schwann cells indicative of re-
myelination (Fig. 4A–C). In contrast, periaxin-null peripheral
nerves aremore severely affected, and normalmyelin profiles at 6
months are very rare (Gillespie et al., 2000). Although g ratios in
the mutant were not significantly different at P21 (0.63  0.01
and 0.65  0.02; mean values  SEM; n  3 for control and
mutant, respectively) as we have found previously for periaxin-
null quadriceps nerves at the same age (Court et al., 2004), by 3.5
months overproduction of myelin was reflected in a decrease in g
ratio, which was recapitulated after crush injury. (Fig. 4E). Sim-
ilar hypermyelination has been observed in periaxin-null
Schwann cells and seems to be a prelude to demyelination (Gil-
lespie et al., 2000). These differences in g ratio were not accom-
panied by any significant difference in axon diameter between
control and mutant nerves at 3 weeks (2.47  0.10 and 2.76 
0.07 m; mean values  SEM; n  3, respectively) or at 3.5
months (3.75 0.32 and 3.50 0.19 m; mean values SEM;
n 3, respectively) in sciatic nerves.
Unlike periaxin, Drp2 is not a component of Schmidt-
Lanterman incisures, the cytoplasm-filled channels in PNS my-
elin. Nevertheless, since loss of Drp2 caused changes in the
organization of the Schwann cell cytoplasm in theCajal bands, we
wondered whether Schmidt-Lanterman incisures were also af-
fected. Surprisingly, at 6 weeks of age, we found that these in-
Figure 2. Loss of Drp2 causes disruption of appositions. A, Immunofluorescence for S100 protein (green) and stainingwith Alexa Fluor 568-phalloidin formicrofilaments (red) shows that loss of
Drp2 disrupts Cajal bands. Scale bar, 10m. B, Electronmicroscopy of nerve transverse sections shows loss of appositions in mutants. Scale bar, 2m. C, Quantitation of appositions from Drp2fl/Y
andmutantmice at P21 and P42 expressed as a frequency distribution. Values for the frequency of each number of appositions aremeans SEM (n 3mice).D, Pseudocolor surface plot ofmean
internodal signal intensity shows thatMBPmRNA inDrp2fl/Y Schwann cells (n 15) accumulates in the perinuclear and paranodal domains,whereas in DRP2mutants lacking Cajal bands the signal
declines from the perinuclear region toward the paranodes (n 17) as observed in periaxin-null (Prx/) Schwann cells (n 17). Nuclei and nodes of Ranvier are indicated by asterisks and
arrowheads, respectively.
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cisures are more numerous in Drp2 mutant Schwann cells
(2.24  0.07 100 m1 and 3.67  0.02 100 m1; mean val-
ues SEM; n 2 for control andDrp2mutant, respectively; p
0.0001). The number of incisures did not change with further
development when measured at 9 weeks (2.25 0.01 100 m1
and 3.69  0.02 100 m1; mean values  SEM; n  3 for
control and Drp2 mutant, respectively; p  0.0001). This is in
contrast to periaxin-null Schwann cells in which Schmidt-
Lanterman incisures are lost (Gillespie et al., 1994; Scherer et al.,
1995) (Fig. 5). This underlines the fact that, although both are
components of the dystroglycan complex, loss of Drp2 and peri-
axin can have differential effects on peripheral nerve structure
and function. Insofar as Schmidt-Lanterman incisures may serve
as conduits for communication between the Schwann cell body
and the inner myelin tongue, the fact that they are not reduced in
number suggests that they are not malfunctioning and thus con-
tributing to the pathology of the Drp2-null mouse.
Loss of Drp2 causes upregulation of other Dystrophins but
not enhanced cleavage of -dystroglycan
Loss of dystrophin in skeletal muscle leads to a compensatory
twofold increase in utrophin, and transgenically expressed utro-
phin can significantly reduce dystrophic pathology in the skeletal
muscles of mice lacking dystrophin (Tinsley et al., 1996; Mogha-
daszadeh et al., 2003). Hence, we asked whether there was in-
creased expression of the dystrophin family members Dp116 and
utrophin in Drp2-null Schwann cells. We did observe increased
levels of Dp116 and utrophin, but not - or -dystroglycan, in
Drp2 mutant nerves (Fig. 6A) (Albrecht et al., 2008); similar
increases were not observed in periaxin-null mice, possibly be-
cause they still express Drp2 (Fig. 6A).
A model has been proposed in which Dp116 and utrophin in
the plasmamembrane domains associated with Cajal bands pref-
erentially associate with the cleaved form of -dystroglycan,
whereas the PDG complex in Schwann cell appositions contains
intact -dystroglycan (Court et al., 2011). Certainly, -dystro-
glycan is very susceptible to cleavage to a 31 kDa form by two
matrix metalloproteinases, MMP2 and MMP9 (Yamada et al.,
2001; Matsumura et al., 2005; Hnia et al., 2006; Zhong et al.,
2006). However, we did not detect significant amounts of this
cleaved form in control, mutant or periaxin-null nerves when
nerves were lysed in the presence of 1,10-phenanthroline, a
highly effective inhibitor of MMPs (Fig. 6A). Neither was this
cleaved species present in the pellet after vigorous centrifugation
of the lysate. A faint but variable signal of the breakdown product
could be detected (Fig. 6A), but in five different experiments
there was no correlation between the genotype of the mouse and
the amount of 31 kDa -dystroglycan, and it never represented
	1–2% of total -dystroglycan. Hence, disruption of the PDG
complex does not appear to activate the MMPs. We compared
the amounts of 31 kDa-dystroglycan in peripheral nerve lysates
with and without 1,10-phenanthroline. This confirmed that the
intact protein that migrates at 43 kDa is the normal species in
peripheral nerves but that it is very susceptible to proteolysis in
the absence of the MMP inhibitor (Fig. 6A,B).
Drp2 phosphorylation and recruitment to appositions
requires interaction with periaxin
Loss of periaxin in Schwann cells results in increased Drp2 mo-
bility in SDS-PAGE (Fig. 6A). We asked whether this shift
reflected a change in phosphorylation status and, if so, phosphor-
ylation might play a role in apposition formation. Treatment of
peripheral nerve extracts fromwild-type mice with calf intestinal
phosphatase in the presence or absence of phosphatase inhibitors
showed that Drp2 is phosphorylated (Fig. 7A). The two major
sites of phosphorylation were shown by mass spectrometry to be
S748 and T910 (Fig. 7B), and these were confirmed by in vitro
kinase assays (Fig. 7C).
Phosphorylation at these sites survived lysis in the absence of
phosphatase inhibitors suggesting that they are protected, possi-
bly through interaction with periaxin in vivo. This was supported
by the fact that Drp2 from periaxin-null nerves was dephospho-
rylated even when lysates were prepared with phosphatase
inhibitors (Fig. 8A). The role of periaxin in promoting Drp2
phosphorylation was also demonstrated in periaxin heterozy-
gous-null nerves, which have reduced levels of periaxin (Gillespie
et al., 2000). As the animals get older, periaxin levels increase with
a concomitant shift towardmore phosphorylatedDrp2 (Fig. 8B).
Since loss of appositions is associated with a shift to the de-
phosphorylated form of Drp2, we asked whether nonphosphory-
lated Drp2 could still assemble into appositions. We generated
transgenic mice that expressed wild-type and mutant Drp2 in
which the two major phosphorylation sites were mutated on a
Drp2-null background.We usedmice expressing wild-type Drp2
on aDrp2-null background rather thanwild-typemice to control
for the presence of the FLAG tag and the timing of expression
using a heterologous promoter. Western blots showed that the
levels of wild-type andmutant Drp2 and the amounts of periaxin
in the respective transgenics were similar (Fig. 8C). The blots also
showed that themobility of themutant nonphosphorylatedDrp2
was increased as predicted (Fig. 8C). Immunofluorescence anal-
ysis of Drp2 showed that recruitment to appositions did not re-
quire phosphorylation at these sites (Fig. 8D).
We next wanted to determine whether direct interaction be-
tween periaxin and Drp2 was necessary for apposition formation
andDrp2 phosphorylation. Transgenicmice were generated on a
Prx/ background expressing either wild-type periaxin or a
Figure 3. Loss of Cajal bands does not cause functional deficits. A, Internodal lengths of
control (Drp2fl/Y) quadriceps nerves compared with mutants at P21 (n 3) and P90 (n 4).
Values aremeans SEM.B, Nerve conduction velocitiesweremeasured in control andmutant
mice at P90 (n 4) and at P180 (n 8). Values are means SEM. C, Latency to fall on the
accelerating Rotarodwasmeasured during successive trials for control andmutantmice at P90
and P180. Values are means SEM (n 13 mice for each condition). For A–C, control and
mutant values for each condition were not significantly different.
Sherman et al. • Role of Drp2 in Forming Cajal Bands J. Neurosci., July 4, 2012 • 32(27):9419–9428 • 9423
periaxin mutant lacking the basic domain (amino acids 130–
199), which is known to be essential for interaction with Drp2
(Sherman et al., 2001). Levels of transgenically encodedwild-type
and mutant periaxin were similar (Fig. 8C). Loss of periaxin in-
teraction with Drp2 reduced the phosphorylation of Drp2, and
Drp2-positive appositions were disrupted (Fig. 8C,D). The effect
of complete loss of periaxin inPrx/mutant sciatic nerves com-
pared with WT mice is shown for comparison (Fig. 8C). Despite
the loss of Cajal bands, internodal lengths in the periaxin mutant
lacking the Drp2 binding domain were normal (PrxTG/Prx/,
498.4  10.0 m; PrxTG/Prx/, 528.0  6.8 m; mean val-
ues  SEM; n  3). Hence, from these data we concluded that,
although phosphorylation of Drp2 was not essential for the
Figure6. Compositionof Schwann cell dystroglycan complexes in theabsenceof eitherDrp2
or periaxin. A, Western blot of sciatic nerve lysates shows that loss of Drp2 causes complemen-
tary increases in utrophin and the dystrophin isoform, Dp116. Only traces of the cleaved formof
-dystroglycan (-DG 31) were detected in the presence of the MMP inhibitor 1,10-
phenanthroline (5 mM). B, Preparation of sciatic nerve lysates with or without 1,10-
phenanthroline (PHEN) showed that -dystroglycan is susceptible to proteolytic breakdown
during sample preparation. Actin was the loading control.
Figure 4. Disrupted myelination in Drp2 mutant mice. A, Transverse sections showed increasing numbers of aberrant myelin profiles in the mutant with age. Scale bar, 10m. B, C, Electron
micrographs of mutant nerves showing hypermyelination and onion bulbs. Scale bars: B, 1m; C, 2m. D, Percentage of abnormal myelinated axon profiles with age in control and mutant
quadriceps nerves. Values aremeans SEM,where n 3mice for each condition; **p 0.005; ***p 0.0005. E, Mean values of g ratios in uncrushed (contralateral) and crushed (distal) sciatic
nerves from 3.5-month-old mice 6 weeks after crush. Mutant nerves have lower g ratios. Values are means SEM, where n 3 mice for each condition; *p 0.05; **p 0.005.
Figure 5. Immunofluorescence staining of Schmidt-Lanterman incisures in teased fibers
from Drp2fl/Y, Drp2 mutant, and periaxin-null mice. Incisures are stained with antibodies
against Neurofascin (green) and E-cadherin (red). Scale bar, 25m.
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assembly of appositions, and therefore Cajal bands, it was an
excellent index of periaxin–Drp2 interaction in appositions.
To further explore the relationship between the formation of
appositions and Drp2 phosphorylation, we wanted to analyze
peripheral nerves from another mutant where appositions might
be either abnormal or absent. Mice lacking utrophin were of
interest since we had observed upregulation of utrophin in the
absence of Drp2 (Fig. 6A) and thesemice have Schwann cells that
have been reported to have disrupted appositions (Court et al.,
2009). However, we found their Drp2-stained appositions to be
normal (Fig. 8E). Furthermore, and in accord with predictions
from the data above, Drp2 was phosphorylated in utrophin-null
nerves, which provided an independentmeasure of the intactness
of appositions in addition to immunofluorescence (Fig. 8F).
Discussion
We have shown by disrupting appositions in myelinating
Schwann cells through the loss of Drp2 that these structures and
their associated Cajal bands are required to regulate the radial
growth of myelin and prevent focal hypermyelination. This work
has also demonstrated that Cajal bands do not have an essential
role in the regulation of Schwann cell elongation and thus in
determining internodal length. We have also been able to evalu-
ate a recent model proposed for the regulation of Cajal band size
(Court et al., 2011).
Recent quantitative studies have shown that periaxin com-
prises 16% by weight of PNS myelin protein, whereas Drp2
represents
0.2% (Patzig et al., 2011). These values are not con-
sistent with an exclusive stoichiometric relationship between
periaxin and Drp2 in a dystroglycan complex and suggest that
periaxin has roles beyond its participation
in forming the PDG complex and apposi-
tions. Loss of periaxin disrupts apposi-
tions, impairs Schwann cell elongation,
reduces nerve conduction velocity, and
causes focal hypermyelination and demy-
elination (Gillespie et al., 2000; Sherman
et al., 2001; Court et al., 2004). Further-
more, mutations in the Periaxin gene in
humans cause Charcot–Marie–Tooth dis-
ease 4F (Boerkoel et al., 2001; Guilbot et
al., 2001; Takashima et al., 2002). In con-
trast, the loss of Drp2 or the disruption of
dystroglycan complexes by Schwann cell-
specific loss of dystroglycan have much
less severe phenotypes (Saito et al., 2003).
A very clear difference between pe-
ripheral nerves lackingDrp2 or periaxin is
the effect on Schmidt-Lanterman incisures.
Although their function is still not com-
pletely understood, it is assumed that they
act as conduits for the delivery of nutrients
and/ormyelin components to the inner lay-
ers of the myelin sheath. Periaxin is a con-
stituent of the incisures but Drp2 is not
(Gillespie et al., 2000; Sherman et al., 2001).
This may explain why the incisures are de-
ranged in periaxin-null Schwann cells,
whereas they are actually increased in num-
ber in the absence of Drp2. In Drp2 mu-
tants, excess periaxin no longer interacting
withDrp2might be available for participat-
ing in incisure formation, so generating an
increased number of incisures.
In similar vein, in Drp2mutant nerves, we observed increased
levels of Dp116 and utrophin, but not - or -dystroglycan. This
suggests that, in the absence of Drp2, other dystrophin family
members supplant Drp2 in dystroglycan complexes, while the
number of these complexes remains relatively constant. How-
ever, since the Dp116 and utrophin complexes are concentrated
in the plasma membrane contiguous with Cajal bands, they
would not be able to functionally replace Drp2 in forming appo-
sitions (Albrecht et al., 2008). Periaxin-null Schwann cells do not
display the same increased levels of ofDp116 and utrophin, prob-
ably because they still express Drp2.
The cleaved 31 kDa form of -dystroglycan has been reported
to represent a substantial fraction of total -dystroglycan in pe-
ripheral nerves (Yamada et al., 2001; Zaccaria et al., 2001; Court
et al., 2011), although it is only significant in skeletal muscle or
brain under pathological conditions (Yamada et al., 2001; Zacca-
ria et al., 2001; Matsumura et al., 2005; Shang et al., 2008). A
model has been proposed recently suggesting that dystroglycan
complexes containing Dp116 and utrophin in the plasma mem-
brane domains associated with Cajal bands preferentially associ-
ate with the cleaved 31 kDa form of -dystroglycan, whereas the
PDG complex in Schwann cell appositions contains intact
-dystroglycan (Court et al., 2011). Regulated conversion of
-dystroglycan to its cleaved formwould then control the relative
sizes of appositions and therefore Cajal bands.
The proteinases responsible for cleavage of dystroglycan,
MMP2 and MMP9, are highly susceptible to activation by deter-
gents (Birkedal-Hansen andTaylor, 1982; Birkedal-Hansen et al.,
1993), and SDS-mediated activation of proteolysis as a result of
Figure 7. Drp2 is phosphorylated. A, Western blots of nerve lysates treated with calf intestinal phosphatase (CIP) with or
withoutphosphatase inhibitors (PI) shows thatDrp2 is phosphorylated.B, PhosphopeptidemappingofDrp2bymass spectrometry
identified S748 and T910 as the primary sites of phosphorylation. C, In vitro phosphorylation of GST fusion proteins containing the
C-terminal region of Drp2 (amino acids 723–957) with peripheral nerve lysates in the presence of [- 32P]ATP. Mutation of either
S748 or T910 to alanine reduced phosphorylation. Coomassie Blue staining shows the amounts of the GST proteins were
comparable.
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substrate unfolding is also a potential compli-
cation (Linderstrom-Lang and Moller, 1953;
Reynolds and Tanford, 1970; Beynon,
1988). Interestingly, when we used 2% SDS
instead of our normal lysis buffer, degrada-
tion of -dystroglycan to the cleaved form
was considerably accentuated in the absence
of the MMP inhibitor 1,10-phenanthroline
(data not shown), which could also have
been caused by more effective activation of
the MMPs by SDS. Importantly, we found
that inclusion of 1,10-phenanthroline effec-
tively prevented generation of the cleaved
-dystroglycan during nerve lysis. This sug-
gests that high activities of MMP2 and
MMP9 are intrinsic to the nerve and do not
result from the invasion of macrophages
that normally accompanies pathology (Li et
al., 2009).
From our work and that of others, we
conclude that the model by which Cajal
band segregation is regulated by means of
MMPs (Court et al., 2011) is unlikely for
the following reasons. In this model, ap-
positions are proposed to be enriched in
intact -dystroglycan, whereas the -dy-
stroglycan found outside appositions in
Cajal bands is proposed to be the proteo-
lysed, cleaved form. Hence, a prediction
from the model is that loss of appositions
in Drp2- and periaxin-null nerves would
lead to a reduction in intact -dystro-
glycan and a substantial increase in cleaved
-dystroglycan. However, this is not the case
(Fig. 6A). Second, the model predicts that
Dp116 inCajal bandswouldpreferentially in-
teractwiththecleavedformof-dystroglycan.
Wehave indeedpreviously shownthatDp116
is segregated to Cajal bands (Sherman et al.,
2001; Albrecht et al., 2008), and this was con-
firmed byCourt et al. (2011).However, it has
beenpreviouslydemonstrated experimentally
by Mornet’s group (Hnia et al., 2006) that
Dp116 in Schwann cells preferentially inter-
actswithuncleaved, intact-dystroglycanand
not the cleaved form. Finally, and we believe
most conclusively, we have shown that the
generation of cleaved -dystroglycan in peripheral nerve extracts is an
adventitious consequence of proteolysis during nerve lysis (Fig. 6B).
Although we have shown that -dystroglycan is uncleaved in
myelinating Schwann cells, it is still unclear how the PDG com-
plex segregates from the two other dystroglycan complexes that
use utrophin and the dystrophin isoform Dp116. In contrast to
Court et al. (2009), we find that Schwann cells lacking utrophin
have normal appositions, Cajal bands, and normally phosphory-
lated Drp2. Hence, it seems unlikely that the utrophin–dystro-
glycan complex has a role in cytoplasmic compartmentalization
or that the upregulation of utrophin seen in Drp2-null Schwann
cells compensates functionally for loss of Drp2. AlthoughDrp2 is
normally phosphorylated in the PDG complex when Drp2 and
periaxin interact at appositions, recruitment of Drp2 to apposi-
tions did not require phosphorylation at the major sites that we
identified. However, we cannot exclude possible compensatory
phosphorylation at new sites. The role of phosphorylation will be
the subject of future work.
Periaxin and Drp2 are not only essential to form the PDG
complex but they must also interact. Nevertheless, the presence
of periaxin, even without the Drp2 binding domain, ensures that
Schwann cell elongation is normal and further underlines the
importance of this protein in the regulation of Schwann cell
growth independent of its role in forming Cajal bands. This ex-
periment provides further support for our conclusion that inter-
nodal lengths are not regulated by appositions and Cajal bands.
Crucially, our ability to uncouple Cajal band disruption from the
regulation of Schwann cell elongation has revealed a distinct and
vital role for periaxin in peripheral nerve development.
Howmight disruption of Cajal bands cause focal hypermyeli-
nation? The close association of the PDG complex with the
myelin sheath, the Schwann cell plasma membrane, and the in-
Figure 8. Drp2 is phosphorylatedwhen complexedwith Periaxin in appositions.A, Preparation of nerve lysates from eitherWT
or periaxin-null nerves (Prx/) in the presence of phosphatase inhibitors showed that Drp2 is not dephosphorylated during
extraction. B, Mice heterozygous null for Prx accumulate periaxin with age with a concomitant shift of Drp2 to a more phosphor-
ylated state. Actin was used as a loading control. C, Western blots showing the expression and phosphorylation state of Drp2 in
nerves from transgenic mice expressing wild-type Drp2 (Drp2Tg/Drp2/) or the phosphorylation site mutant (Drp2PTg/
Drp2/) on a Drp2-null background, and from transgenic wild-type periaxin (PrxTg/Prx/) or a mutant lacking the Drp2
binding domain (PrxTg/Prx/) on a periaxin-null background. Control lanes show periaxin and Drp2 fromWT and periaxin-
null (Prx/) nerves, respectively. Actin was used as a loading control. D, Immunofluorescence of Drp2 localization in teased
quadriceps fibers from Drp2Tg/Drp2/ and Drp2PTg/Drp2/mice and from PrxTg/Prx/ and PrxTg/Prx/mice.
Scale bar, 10 m. E, F, Immunofluorescence localization of Drp2 in quadriceps nerves from 6-week-old utrophin-null mice
(Utr/) was indistinguishable from controls.Western blot analysis showed that Drp2 is also phosphorylated. Scale bar, 10m.
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teraction with basement membrane is likely to promote the me-
chanical stability of peripheral nerves to prevent their damage as
has been found for the dystroglycan complexes of skeletal muscle
(Han et al., 2009). This is likely to be important in the PNS
because it is vulnerable to quotidian insult. Although we have
shown that loss of Cajal bands in Drp2-null nerves does not pre-
vent remyelination after nerve crush, we propose that disruption
of this complex that mechanically links the extracellular milieu
with themyelin sheath could lead to cumulative long-term insta-
bility that is reflected in the age-related accumulation of abnor-
mal myelin profiles and focal hypermyelination.
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